| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | EVP, Chief Operating Officer | Common Stock | 52,000 | $11,856 | $0.2280 | 01 Jan 2025 | Direct |
| BRAINSTORM CELL THERAPEUTICS INC. | EVP, Chief Operating Officer | Stock Option (Right to Buy) | 60,000 | 24 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 01 Jan 2025 | 1 | $0 | 4 | EVP, Chief Operating Officer | 03 Jan 2025, 17:31 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 24 Jun 2024 | 2 | $0 | 4 | EVP, Chief Operating Officer | 25 Jun 2024, 21:04 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 24 Jun 2024 | 0 | $0 | 3 | EVP, Chief Operating Officer | 25 Jun 2024, 21:03 |